Results 241 to 250 of about 62,239 (284)

Case report: Cilioretinal artery occlusion combined with central retinal vein occlusion as the initial presentation of pulmonary arterial hypertension. [PDF]

Front Med (Lausanne)
Gao Y, Xie X, Li J, Mu Q, Wang X, Wang S.   +5 more
europepmc   +1 more source

Central retinal vein occlusion study

Indian Journal of Ophthalmology, 1997
Sangha Kulwinder
doaj  

Impact of high-risk optic disc on central retinal vein occlusion in patients with metabolic disorders. [PDF]

Front Physiol
Si S, Lin J, Guo R, Chen A, Ji Y.
europepmc   +1 more source

The Effect of Central Retinal Venous Pressure in Patients with Central Retinal Vein Occlusion and a High Mean Area of Nonperfusion

, 2014
Ian L. McAllister, Mei Hong Tan, Lynne A. Smithies, Wan Ling Wong   +3 more
openalex   +2 more sources

Effects of intravitreal Bevacizumab (Avastin) monotherapy in central retinal vein occlusion in young subjects. [PDF]

Rom J Ophthalmol
Lobo S, Vivekanand U, Lobo GJ.
europepmc   +1 more source

A rare case of systemic lupus erythematosus presenting with concurrent myocarditis, central retinal vein occlusion, and deep vein thrombosis. [PDF]

Clin Case Rep
Fesharaki MJ, Dehkordi NR, Zakeri Z, Hosseinjani E, Dehkordi NR.   +4 more
europepmc   +1 more source

Combined central retinal vein occlusion and cilioretinal artery occlusion in an MTHFR C677T homozygous 26-year-old patient with hyperhomocysteinemia: Case report

Estelle Ioannidou, Vasilis‐Spyridon Tseriotis, Maria Syriga, Thanos Blougouras, Vasileios Soumplis, Michael Karampelas   +5 more
openalex   +1 more source

Complement C3 is downregulated following ranibizumab intervention in experimental central retinal vein occlusion. [PDF]

Mol Vis
Cehofski LJ, Kruse A, Mæng MO, Kjaergaard B, Sejergaard BF, Schlosser A, Sorensen GL, Honoré B, Vorum H.   +8 more
europepmc   +1 more source

Corrigendum to "Randomized Study of Intravitreal Autologous CD34+ Stem Cells in Central Retinal Vein Occlusion (Treatment of Retinal vein occlusion Using STem cells [TRUST] Report 1): Safety and Feasibility. Ophthalmol Sci. 2026;6:100905". [PDF]

Ophthalmol Sci
europepmc   +1 more source